A well-equipped team and sound approach make Hartford Healthcare an attractive healthcare option.
Hartford Healthcare A HGHAX
- NAV / 1-Day Return 40.84 / +0.32 %
- Total Assets 1.1 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.270%
- Distribution Fee Level Average
- Share Class Type Front Load
- Category Health
- Investment Style Large Growth
- Min. Initial Investment 2,000
- Status Open
- TTM Yield 0.00
- Turnover 32%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis HGHAX
Will HGHAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 42.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 11.41 | 131.2 Mil | Healthcare |
UnitedHealth Group Inc | 8.70 | 100.1 Mil | Healthcare |
Merck & Co Inc | 3.59 | 41.3 Mil | Healthcare |
Danaher Corp | 3.54 | 40.7 Mil | Healthcare |
Boston Scientific Corp | 3.25 | 37.4 Mil | Healthcare |
Thermo Fisher Scientific Inc | 2.90 | 33.4 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 2.51 | 28.9 Mil | Healthcare |
Stryker Corp | 2.37 | 27.2 Mil | Healthcare |
HCA Healthcare Inc | 2.18 | 25.1 Mil | Healthcare |
AstraZeneca PLC ADR | 2.05 | 23.5 Mil | Healthcare |